Correspondence 0001104659-24-096400 from Baird Medical Investment Holdings Ltd (BDMD) (CIK 0001982444) (BDMD)
Baird Medical Investment Holdings Ltd (BDMD) (CIK 0001982444)
Date: Sept. 3, 2024 · CIK: 0001982444 · Accession: 0001104659-24-096400
AI Filing Summary & Sentiment
File numbers found in text: 333-274114
Letter
BAIRD MEDICAL INVESTMENT HOLDINGS LIMITED
Room 202, 2/F, Baide Building, Building 11, No.15
Rongtong Street, Yuexiu District, Guangzhou, Peoples Republic of China
September 3, 2024
VIA EDGAR
Tracey Houser
Jeanne Baker
Conlon Danberg
Lauren Nguyen
Jane Park
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
F Street, N.E.
Washington, D.C. 20549
Re: Baird Medical Investment Holdings Limited
Registration Statement on Form F-4
(File No. 333-274114)
Originally filed on August 21, 2023, as amended
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Baird Medical Investment Holdings Limited (the “Registrant”) hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form F-4 to become effective on Thursday, September 5, 2024, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable.
The Registrant requests that it be notified of such effectiveness by a telephone call to Stephen Leitzell, Esq. of Dechert LLP, counsel to the Registrant, at (215) 994-2621 or by an email to stephen.leitzell@dechert.com.
Thank you for your assistance. If you should have any questions, please contact Mr. Leitzell at (215) 994-2621.
Very
truly yours,
/s/
Haimei Wu
Show Raw Text
CORRESP
1
filename1.htm
BAIRD
MEDICAL INVESTMENT HOLDINGS LIMITED
Room
202, 2/F, Baide Building, Building 11, No.15
Rongtong Street, Yuexiu District, Guangzhou, Peoples Republic of China
September
3, 2024
VIA
EDGAR
Tracey
Houser
Jeanne
Baker
Conlon
Danberg
Lauren
Nguyen
Jane Park
United
States Securities and Exchange Commission
Division
of Corporation Finance
Office
of Industrial Applications and Services
100
F Street, N.E.
Washington,
D.C. 20549
Re:
Baird
Medical Investment Holdings Limited
Registration
Statement on Form F-4
(File
No. 333-274114)
Originally filed on August 21, 2023, as amended
Ladies
and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended, Baird Medical Investment Holdings Limited (the “Registrant”)
hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement
on Form F-4 to become effective on Thursday, September 5, 2024, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable.
The
Registrant requests that it be notified of such effectiveness by a telephone call to Stephen Leitzell, Esq. of Dechert LLP, counsel to
the Registrant, at (215) 994-2621 or by an email to stephen.leitzell@dechert.com.
Thank
you for your assistance. If you should have any questions, please contact Mr. Leitzell at (215) 994-2621.
Very
truly yours,
/s/
Haimei Wu
Haimei
Wu
Chief
Executive Officer